Horizon 2020 Health

SC1-DTH-09-2019: Scaling up the univocal Identification of Medicinal Products

Deadline: 24 april 2019

Across the European Union, medicinal products display differences in names, variations in strength or their package size. The unavailability of a specific product may also necessitate substitution in many instances, if a patient is to be timely served in a pharmacy.

This innovation action is expected to support two goals: (i) the cross-border mobility of European patients by offering safer eDispensations across borders, (ii) the implementation of the IDMP standards in Member States drug databases (including a possible linkage to the EU SPOR - Substance, Product, Organisation and Referential master data database) allowing the identification of locally available medicinal products which are equivalent to the one identified in a foreign prescription.

Financiert projecten binnen:

De officiële aanmelding van Horizon 2020 Health

Contact betreffende subsidie van Horizon 2020 Health

Past deze aanmelding bij uw project? We nemen graag contact met u op voor een vrijblijvend advies over de Horizon 2020 Health subsidiemogelijkheden voor uw project.

Over Horizon 2020 Health

With support from Horizon 2020 Health you will be able to conduct international research projects in support of EU policies for health. Support will be given to projects aimed at: Health promotion and prevention; diagnosis improvement; innovative treatments and technologies; active and healthy aging; citizen-centered care; and improving health information etc.

Meer over de subsidies